Monte Rosa Therapeutics Inc Dividends

The next dividend date for Monte Rosa Therapeutics Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Monte Rosa Therapeutics Inc (GLUE)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Monte Rosa Therapeutics Inc

Country
USA
Full Time Employees
142

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1b and the NLRP3 inflammasome. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd. to discover and develop MGDs against targets in cancer and neurological diseases. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Owning Monte Rosa Therapeutics Inc Stock on the Dividend Date

If you own Monte Rosa Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Monte Rosa Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Monte Rosa Therapeutics Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Monte Rosa Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Monte Rosa Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Monte Rosa Therapeutics Inc Dividends

You can contact us any time if you would like to ask questions about Monte Rosa Therapeutics Inc dividends or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.